Non Invasive Prenatal Testing Nipt Market
Non Invasive Prenatal Testing (NIPT) Market Forecasts to 2030 - Global Analysis By Product (Disposables, Ultrasound Devices, Assay Kits & Reagents, Polymerase Chain Reaction Instruments, Next-Generation Sequencing Systems, Microarrays and Other Products), Method, Gestation Period, Technology, Application, End User and By Geography
|
Years Covered |
2021-2030 |
|
Estimated Year Value (2023) |
US $4.2 BN |
|
Projected Year Value (2030) |
US $9.1 BN |
|
CAGR (2023 - 2030) |
11.6% |
|
Regions Covered |
North America, Europe, Asia Pacific, South America, and Middle East & Africa |
|
Countries Covered |
US, Canada, Mexico, Germany, UK, Italy, France, Spain, Japan, China, India, Australia, New Zealand, South Korea, Rest of Asia Pacific, South America, Argentina, Brazil, Chile, Middle East & Africa, Saudi Arabia, UAE, Qatar, and South Africa |
|
Largest Market |
North America |
|
Highest Growing Market |
Asia Pacific |
According to Stratistics MRC, the Global Non-Invasive Prenatal Testing (NIPT) Market is accounted for $4.2 billion in 2023 and is expected to reach $9.1 billion by 2030 growing at a CAGR of 11.6% during the forecast period. A DNA-based blood test called non-invasive prenatal testing is used to determine the growing foetus's risk of genetic diseases. A sort of screening test called Non-Invasive Prenatal Testing (NIPT) is used to identify specific genetic disorders in the growing fetus during pregnancy. NIPT is a non-invasive treatment that requires a mother's simple blood test, as opposed to invasive procedures like amniocentesis or chorionic villus sampling (CVS).
According to Eurostat, in 2017, around 45% of women in the European Union who gave birth to their first child belonged to the average age group of 29.1 years. Also, in the same year, around 78,275 births of first children were reported in women aged more than 40 years.
-Market-fig2.png)
Market Dynamics:
Driver:
Need for accurate and sophisticated screening
The development of extremely sophisticated screening methods that are highly sensitive and accurate in the early detection of genetic abnormalities in newborns is a continuing priority for a number of businesses. Manufacturers are placing a lot of emphasis on the creation of cutting-edge noninvasive prenatal diagnostics and forming strategic alliances and collaborations to boost their market share. These are the factors influencing the growth of the market.
Restraint:
Limited availability of counseling
Even while the NIPT offers useful information, people may not always have easy access to enough counseling and assistance to fully comprehend the consequences of the results and make decisions. There may be ethical and legal issues with using NIPT data in some areas due to a lack of defined laws around its usage and interpretation. These are the aspects affecting the market's expansion.
Opportunity:
High risk of chromosomal abnormalities with increasing maternal age
Growing older mothers are more likely to have high blood pressure, limited fertility, miscarriages, stillbirths, and maternal death, among other health problems. Furthermore, the risk of genetic disorders in neonates might increase with maternal age due to improper chromosomal division. Therefore, it is anticipated that the market would be driven by the rising frequency of chromosomal abnormalities along with the aging of mothers.
Threat:
High cost of tests
Growing populations in emerging nations would be hampered by a lack of knowledge about the hazards associated with genetic disorders. However, some other issues that can restrict market expansion include reduced per capita healthcare spending and inadequate test reimbursement rules. The adoption of these tests will be restricted by their high cost, which makes them comparatively unaffordable in many developing nations.
Covid-19 Impact:
Prenatal care was among the regular medical treatments that were difficult to obtain during the pandemic's height. There were some visits that were cancelled or done virtually, which had an impact on the regularity of NIPT and other prenatal tests. In order to handle COVID-19 cases, healthcare resources were reallocated, which could have had an impact on the accessibility of NIPT testing or lengthened wait times for those in need of these services.
The ultrasound detection segment is expected to be the largest during the forecast period
The ultrasound detection segment is expected to be the largest during the forecast period. This is the method that is most favored and used for the ultrasound machine is utilized in this technique. Using a probe, sound pulses with frequency between one and five megahertz are injected into the body during the test. In addition, the probe serves as a receiver for sound waves reflected off tissue surfaces.
The diagnostic laboratories segment is expected to have the highest CAGR during the forecast period
The diagnostic laboratories segment is expected to have the highest CAGR during the forecast period. The testing environment where the test is conducted is a diagnostic laboratory. Various testing services are offered by the laboratories based on the needs of the patients. Because there are so many diagnostic labs and centers that offer testing services and goods, the diagnostic laboratories category is the largest.
Region with largest share:
North America is projected to hold the largest market share during the forecast period. The adoption and demand for testing in this region is expected to rise due to the high prevalence of preterm births, high rate of maternal mortality, and increased occurrences of chromosomal abnormalities. Numerous studies provide light on the efficacy of raising awareness of prenatal care. In addition, the market is expanding due to high diagnosis rates, increased public adoption and awareness, and the release of new, more technologically sophisticated tests.
Region with highest CAGR:
Asia Pacific is projected to hold the highest CAGR over the forecast period owing to the rising maternal age, which contributes to the growing incidence of chromosomal aneuploidies in babies, leading to a rise in the potential customer base. The technical integration of NGS techniques, significant advancements in China and Japan, and enhanced healthcare infrastructure are anticipated to propel market expansion.
Key players in the market
Some of the key players in Non-Invasive Prenatal Testing (NIPT) market include Centogene N.V., Natera, Inc., MedGenome Labs Ltd., Eurofins LifeCodeNon Invasive Prenatal Testing (NIPT) GmbH, F. Hoffmann-La Roche Ltd., Progenity, Inc., Illumina, Inc., Genesis Genetics, Qiagen, Laboratory Corp. of America Holdings, Quest Diagnostics, Inc., Thermo Fisher Scientific Inc., Your gene Health and Perkinelmer, Inc.
Key Developments:
In August 2022, Natera Inc. filed a pre-submission to the Food and Drug Administration (FDA) for its panorama non-invasive prenatal test (NIPT) as part of the Q-Sub process. The company filed its pre-submission in June 2022 for fetal chromosomal aneuploidies and 22q11.2 deletion syndrome.
In July 2022, Genetic Technologies Limited acquired EasyDNA as the company expanded the availability on its websites of Carrier Testing and Non-Invasive Prenatal Tests (NIPT) in Europe.
Products Covered:
• Disposables
• Ultrasound Devices
• Assay Kits & Reagents
• Polymerase Chain Reaction Instruments
• Next-Generation Sequencing Systems
• Other Products
Methods Covered:
• Ultrasound Detection
• Biochemical Screening Tests
• Cell-Free DNA in Maternal Plasma Tests
Gestation Periods Covered:
• 0-12 Weeks
• 13-24 Weeks
• 25-36 Weeks
Technologies Covered:
• Next Generation Sequencing (NGS)
• Microarray
• Rolling Circular Amplification
• Other Technologies
Applications Covered:
• Microdeletion Syndrome
• Trisomy
• Other Applications
End Users Covered:
• Diagnostic Laboratories
• Hospitals
• Other End Users
Regions Covered:
• North America
o US
o Canada
o Mexico
• Europe
o Germany
o UK
o Italy
o France
o Spain
o Rest of Europe
• Asia Pacific
o Japan
o China
o India
o Australia
o New Zealand
o South Korea
o Rest of Asia Pacific
• South America
o Argentina
o Brazil
o Chile
o Rest of South America
• Middle East & Africa
o Saudi Arabia
o UAE
o Qatar
o South Africa
o Rest of Middle East & Africa
What our report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements
Free Customization Offerings:
All the customers of this report will be entitled to receive one of the following free customization options:
• Company Profiling
o Comprehensive profiling of additional market players (up to 3)
o SWOT Analysis of key players (up to 3)
• Regional Segmentation
o Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
o Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances
Table of Contents
1 Executive Summary
2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions
3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Product Analysis
3.7 Technology
3.8 Application Analysis
3.9 End User Analysis
3.10 Emerging Markets
3.11 Impact of Covid-19
4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry
5 Global Non Invasive Prenatal Testing (NIPT) Market, By Product
5.1 Introduction
5.2 Disposables
5.3 Ultrasound Devices
5.4 Assay Kits & Reagents
5.5 Polymerase Chain Reaction Instruments
5.6 Next-Generation Sequencing Systems
5.7 Other Products
6 Global Non Invasive Prenatal Testing (NIPT) Market, By Method
6.1 Introduction
6.2 Ultrasound Detection
6.3 Biochemical Screening Tests
6.4 Cell-Free DNA in Maternal Plasma Tests
7 Global Non Invasive Prenatal Testing (NIPT) Market, By Gestation Period
7.1 Introduction
7.2 0-12 Weeks
7.3 13-24 Weeks
7.4 25-36 Weeks
8 Global Non Invasive Prenatal Testing (NIPT) Market, By Technology
8.1 Introduction
8.2 Next Generation Sequencing (NGS)
8.3 Microarray
8.4 Rolling Circular Amplification
8.5 Other Technologies
9 Global Non Invasive Prenatal Testing (NIPT) Market, By Application
9.1 Introduction
9.2 Microdeletion Syndrome
9.3 Trisomy
9.4 Other Applications
10 Global Non Invasive Prenatal Testing (NIPT) Market, By End User
10.1 Introduction
10.2 Diagnostic Laboratories
10.3 Hospitals
10.4 Other End Users
11 Global Non Invasive Prenatal Testing (NIPT) Market, By Geography
11.1 Introduction
11.2 North America
11.2.1 US
11.2.2 Canada
11.2.3 Mexico
11.3 Europe
11.3.1 Germany
11.3.2 UK
11.3.3 Italy
11.3.4 France
11.3.5 Spain
11.3.6 Rest of Europe
11.4 Asia Pacific
11.4.1 Japan
11.4.2 China
11.4.3 India
11.4.4 Australia
11.4.5 New Zealand
11.4.6 South Korea
11.4.7 Rest of Asia Pacific
11.5 South America
11.5.1 Argentina
11.5.2 Brazil
11.5.3 Chile
11.5.4 Rest of South America
11.6 Middle East & Africa
11.6.1 Saudi Arabia
11.6.2 UAE
11.6.3 Qatar
11.6.4 South Africa
11.6.5 Rest of Middle East & Africa
12 Key Developments
12.1 Agreements, Partnerships, Collaborations and Joint Ventures
12.2 Acquisitions & Mergers
12.3 New Product Launch
12.4 Expansions
12.5 Other Key Strategies
13 Company Profiling
13.1 Centogene N.V.
13.2 Natera, Inc.
13.3 MedGenome Labs Ltd.
13.4 Eurofins LifeCodeNon Invasive Prenatal Testing (NIPT) GmbH
13.5 F. Hoffmann-La Roche Ltd.
13.6 Progenity, Inc.
13.7 Illumina, Inc.
13.8 Genesis Genetics
13.9 Qiagen
13.10 Laboratory Corp. of America Holdings
13.11 Quest Diagnostics, Inc.
13.12 Thermo Fisher Scientific Inc.
13.13 Your gene Health
13.14 Perkinelmer, Inc.
List of Tables
1 Global Non Invasive Prenatal Testing (NIPT) Market Outlook, By Region (2021-2030) ($MN)
2 Global Non Invasive Prenatal Testing (NIPT) Market Outlook, By Product (2021-2030) ($MN)
3 Global Non Invasive Prenatal Testing (NIPT) Market Outlook, By Disposables (2021-2030) ($MN)
4 Global Non Invasive Prenatal Testing (NIPT) Market Outlook, By Ultrasound Devices (2021-2030) ($MN)
5 Global Non Invasive Prenatal Testing (NIPT) Market Outlook, By Assay Kits & Reagents (2021-2030) ($MN)
6 Global Non Invasive Prenatal Testing (NIPT) Market Outlook, By Polymerase Chain Reaction Instruments (2021-2030) ($MN)
7 Global Non Invasive Prenatal Testing (NIPT) Market Outlook, By Next-Generation Sequencing Systems (2021-2030) ($MN)
8 Global Non Invasive Prenatal Testing (NIPT) Market Outlook, By Other Products (2021-2030) ($MN)
9 Global Non Invasive Prenatal Testing (NIPT) Market Outlook, By Method (2021-2030) ($MN)
10 Global Non Invasive Prenatal Testing (NIPT) Market Outlook, By Ultrasound Detection (2021-2030) ($MN)
11 Global Non Invasive Prenatal Testing (NIPT) Market Outlook, By Biochemical Screening Tests (2021-2030) ($MN)
12 Global Non Invasive Prenatal Testing (NIPT) Market Outlook, By Cell-Free DNA in Maternal Plasma Tests (2021-2030) ($MN)
13 Global Non Invasive Prenatal Testing (NIPT) Market Outlook, By Gestation Period (2021-2030) ($MN)
14 Global Non Invasive Prenatal Testing (NIPT) Market Outlook, By 0-12 Weeks (2021-2030) ($MN)
15 Global Non Invasive Prenatal Testing (NIPT) Market Outlook, By 13-24 Weeks (2021-2030) ($MN)
16 Global Non Invasive Prenatal Testing (NIPT) Market Outlook, By 25-36 Weeks (2021-2030) ($MN)
17 Global Non Invasive Prenatal Testing (NIPT) Market Outlook, By Technology (2021-2030) ($MN)
18 Global Non Invasive Prenatal Testing (NIPT) Market Outlook, By Next Generation Sequencing (NGS) (2021-2030) ($MN)
19 Global Non Invasive Prenatal Testing (NIPT) Market Outlook, By Microarray (2021-2030) ($MN)
20 Global Non Invasive Prenatal Testing (NIPT) Market Outlook, By Rolling Circular Amplification (2021-2030) ($MN)
21 Global Non Invasive Prenatal Testing (NIPT) Market Outlook, By Other Technologies (2021-2030) ($MN)
22 Global Non Invasive Prenatal Testing (NIPT) Market Outlook, By Application (2021-2030) ($MN)
23 Global Non Invasive Prenatal Testing (NIPT) Market Outlook, By Microdeletion Syndrome (2021-2030) ($MN)
24 Global Non Invasive Prenatal Testing (NIPT) Market Outlook, By Trisomy (2021-2030) ($MN)
25 Global Non Invasive Prenatal Testing (NIPT) Market Outlook, By Other Applications (2021-2030) ($MN)
26 Global Non Invasive Prenatal Testing (NIPT) Market Outlook, By End User (2021-2030) ($MN)
27 Global Non Invasive Prenatal Testing (NIPT) Market Outlook, By Diagnostic Laboratories (2021-2030) ($MN)
28 Global Non Invasive Prenatal Testing (NIPT) Market Outlook, By Hospitals (2021-2030) ($MN)
29 Global Non Invasive Prenatal Testing (NIPT) Market Outlook, By Other End Users (2021-2030) ($MN)
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.
List of Figures
RESEARCH METHODOLOGY
We at ‘Stratistics’ opt for an extensive research approach which involves data mining, data validation, and data analysis. The various research sources include in-house repository, secondary research, competitor’s sources, social media research, client internal data, and primary research.
Our team of analysts prefers the most reliable and authenticated data sources in order to perform the comprehensive literature search. With access to most of the authenticated data bases our team highly considers the best mix of information through various sources to obtain extensive and accurate analysis.
Each report takes an average time of a month and a team of 4 industry analysts. The time may vary depending on the scope and data availability of the desired market report. The various parameters used in the market assessment are standardized in order to enhance the data accuracy.
Data Mining
The data is collected from several authenticated, reliable, paid and unpaid sources and is filtered depending on the scope & objective of the research. Our reports repository acts as an added advantage in this procedure. Data gathering from the raw material suppliers, distributors and the manufacturers is performed on a regular basis, this helps in the comprehensive understanding of the products value chain. Apart from the above mentioned sources the data is also collected from the industry consultants to ensure the objective of the study is in the right direction.
Market trends such as technological advancements, regulatory affairs, market dynamics (Drivers, Restraints, Opportunities and Challenges) are obtained from scientific journals, market related national & international associations and organizations.
Data Analysis
From the data that is collected depending on the scope & objective of the research the data is subjected for the analysis. The critical steps that we follow for the data analysis include:
- Product Lifecycle Analysis
- Competitor analysis
- Risk analysis
- Porters Analysis
- PESTEL Analysis
- SWOT Analysis
The data engineering is performed by the core industry experts considering both the Marketing Mix Modeling and the Demand Forecasting. The marketing mix modeling makes use of multiple-regression techniques to predict the optimal mix of marketing variables. Regression factor is based on a number of variables and how they relate to an outcome such as sales or profits.
Data Validation
The data validation is performed by the exhaustive primary research from the expert interviews. This includes telephonic interviews, focus groups, face to face interviews, and questionnaires to validate our research from all aspects. The industry experts we approach come from the leading firms, involved in the supply chain ranging from the suppliers, distributors to the manufacturers and consumers so as to ensure an unbiased analysis.
We are in touch with more than 15,000 industry experts with the right mix of consultants, CEO's, presidents, vice presidents, managers, experts from both supply side and demand side, executives and so on.
The data validation involves the primary research from the industry experts belonging to:
- Leading Companies
- Suppliers & Distributors
- Manufacturers
- Consumers
- Industry/Strategic Consultants
Apart from the data validation the primary research also helps in performing the fill gap research, i.e. providing solutions for the unmet needs of the research which helps in enhancing the reports quality.
For more details about research methodology, kindly write to us at info@strategymrc.com
Frequently Asked Questions
In case of any queries regarding this report, you can contact the customer service by filing the “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929
Yes, the samples are available for all the published reports. You can request them by filling the “Request Sample” option available in this page.
Yes, you can request a sample with your specific requirements. All the customized samples will be provided as per the requirement with the real data masked.
All our reports are available in Digital PDF format. In case if you require them in any other formats, such as PPT, Excel etc you can submit a request through “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929
We offer a free 15% customization with every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.
We have 3 different licensing options available in electronic format.
- Single User Licence: Allows one person, typically the buyer, to have access to the ordered product. The ordered product cannot be distributed to anyone else.
- 2-5 User Licence: Allows the ordered product to be shared among a maximum of 5 people within your organisation.
- Corporate License: Allows the product to be shared among all employees of your organisation regardless of their geographical location.
All our reports are typically be emailed to you as an attachment.
To order any available report you need to register on our website. The payment can be made either through CCAvenue or PayPal payments gateways which accept all international cards.
We extend our support to 6 months post sale. A post sale customization is also provided to cover your unmet needs in the report.
Request Customization
We provide a free 15% customization on every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.
Note: This customization is absolutely free until it falls under the 15% bracket. If your requirement exceeds this a feasibility check will be performed. Post that, a quote will be provided along with the timelines.
WHY CHOOSE US ?
Assured Quality
Best in class reports with high standard of research integrity
24X7 Research Support
Continuous support to ensure the best customer experience.
Free Customization
Adding more values to your product of interest.
Safe & Secure Access
Providing a secured environment for all online transactions.
Trusted by 600+ Brands
Serving the most reputed brands across the world.
